Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: neurologic complications of,systemic cancer (Click to remove) Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neurologic Emergencies in Cancer Patients Neurol Clin 16:1-37, Schiff,D.,et al, 1998 Paraneoplastic Myeloneuropathies Neurol 96:e632-e639, Shah, S.,et al, 2021 Sensory Ganglionopathy NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020 Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies SMJ 109:549-553, Gangaraju, R.,et al, 2016 DWI Lesion Patterns in Cancer-Related Stroke-Specifying the Phenotype Cerebrovasc Dis Extra 5:139-145, Schwarzbach, C.J.,et al, 2015 The Diagnosis and Treatment of Limbic Encephalitis Acta Neurol Scand 126:365-375, Asztely, F. & Kumliem, E., 2012 Diagnostic Evaluation of Patients with a Brain Mass as the Presenting Manifestation of Cancer Neurol 65:908-911, Mavrakis,A.N.,et al, 2005 Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes JNNP 75:1135-1140,1090, Graus,F.,et al, 2004 Spinal Epidural Metastasis as the Initial Manifestation of Malignancy:Clinical Features and Diagnostic Approach Neurol 49:452-456, Schiff,D.,et al, 1997 Showing articles 0 to 12 of 12